Webinar Includes : All the training handouts , certificate ,Q/A and 90 mins Live Webinar
The current pandemic has turned the global focus on the issues surrounding the patenting and protection of COVID-19 vaccines, drugs, and other treatments. On the one hand, companies and institutions developing these treatments want to protect their innovations. Like other patent claims, compound, composition, and method claims for vaccines must have novel, non-obvious, and useful properties. They may also include multiple layers of patents from formulations to manufacturing to methods of use. On the other hand, public interest in getting access to vaccines is at an all-time high. Issues such as compulsory licensing, march-in rights, and IP waivers have all been mentioned in helping countries get access to treatments and avoid infringement. This presentation will discuss not only the global patenting issues facing vaccines but will also look at some of the challenges facing vaccine patenting.
Why Should You Attend
To understand the intellectual property and patent issues surrounding the developing of COVID-19 vaccines and treatments.
- Overview of vaccines
- COVID-19 vaccines in development
- Patentability considerations for compound, composition, and method of use patents
- Patent licensing issues including compulsory, march-in rights, IP waivers
Key Learning Objectives
- Understand the patentability issues facing vaccine patents
- Understand the patentability issues facing method of treatment claims
- Understand the public health interests in accessing COVID-19 vaccines and treatments, including compulsory licensing, march-in rights, and IP waivers play
Who Will Benefit
- C-level executives in companies developing vaccines
- Anyone interested in understanding the current situation surrounding the development of COVID-19 vaccines
Life Sciences IP attorney for Entrepreneurs and Start-ups, Educator, International Speaker, and Author
Joanna is a patent attorney who focuses her practice on all aspects of services related to patents in the areas of biotechnology, pharmaceuticals and medical devices, including patentability opinions, patent drafting, domestic and foreign patent prosecution, development and management of patent portfolios, and general client counseling during all phases of a product’s lifecycle, from concept to commercialization
Joanna’s patent experience covers a variety of complex and innovative inventions involving small molecule drugs, biologics, cell-based technologies, compositions, drug formulations and drug delivery systems, immunotherapeutics, medical devices, diagnostic tests, and immunology, particularly vaccines and antibodies. Joanna also has experience counseling clients on the Hatch-Waxman Act and is monitoring developments involving biosimilars under the Biologics Price Competition and Innovation Act.
Our Participants Testimonial
The presentation by Carolyn Troiana today was fantastic, both I and the QA Manager (Aaron Neighbour) loved it and had extensive conversation afterward about it. ( FDA Compliance and Mobile Applications Webinar )
Robert Friedland ( IT Manager) NUTEK BRAVO, LLC.
Thank you for providing the information in such detail. It was helpful to gain the perspective of somebody that has implemented these regulations in a working lab. Virtual Seminar on ( Training on Life cycle Management of Analytical Methods and Procedures - according to new FDA and USP guidelines )
Tracey Kessler ( Director of R&D) CEL-SCI Corporation
I felt the seminar was very helpful and provided good insight for DataIntegrity and what the FDA is looking for per the regulations. ( Current Regulatory Thinking on Data Integrity 2 Days Virtual Seminar )
Margaret A. Clifton ( Manager, Quality Systems) CSL Plasma
The presenters subject matter knowledge is extensive which enables information to be shared in detail. (Training Attended on Risk Based Verification and Validation Planning to Meed US FDA and ISO 13485 Requirements )
Stuart Chisholm (Sr. Principal Device Engineer) Teva Pharmaceuticals
Top FDA Featured Courses
Knock, knock, who’s there? Are you ready for an FDA inspection in the COVID-19 Era and Beyond?
MP3 Download This webinar will help you manage inspections efficiently and effectively. You’ll learn about the FDA’s inspectional approach, focus areas
How FDA trains its investigators to review CAPA and what should you do to prepare
MP3 Download This webinar will discuss all the documents used by FDA to train their inspectors to review your CAPA system, some of which you may not be familiar
About World Compliance Seminars (WCS)
World Compliance Seminars (WCS) is one stop solution for all your pharmaceutical, biotechnology and medical device certification program needs. The pharmaceutical and medical device training requirements are set forth by the FDA (Food and Drug Administration) and other major regulatory bodies like NIH, EMA, as well as numerous European based national regulatory bodies.
These requirements are important to the training of pharmaceutical reps who are responsible for the education, professional development, and on-the-job training. The training is broken down into different sections to cover a wide variety of topics, including pharmaceutical formulation, pharmaceutical transfer processes , GLP, GMP, Clinical Compliance, Process Validation, Global Regulatory Affairs, Document Management,GMP (Good manufacturing practice) QSR and CMC and many more.
The pharmaceutical and medical device requirements that the FDA has set forth are designed to protect the public's health and safety. Pharmaceutical reps must adhere to all of the regulations and education courses provided by the FDA in order to be considered one of the best in their field. They also must complete ongoing educational opportunities and maintenance programs in order to maintain relevance and career enhancement.